CCELCryo-Cell International, Inc.

$26M

Q1 2017 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$6M+12.1% YoY

Gross Profit

$4M73.8% margin

Operating Income

$1M19.3% margin

Net Income

$486,9238.4% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$429,059

Free Cash Flow

$426,138

Stock-Based Comp.

$77,357

Balance Sheet

Total Assets

$20M

Total Liabilities

$35M

Stockholders' Equity

-$15M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+12.1%
Gross Profit	$4M	$4M	+12.0%
Operating Income	$1M	$156,422	+613.5%
Net Income	$486,923	-$122,936	+496.1%

Revenue Segments

Umbilical Cord Blood And Cord Tissue Stem Cell Service

$6M97%

Prepacyte-CB

$164,8003%

CCEL Q1 2017 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena